Moscow. May 22. INTERFAX.RU — Staff of the national research centre of epidemiology and Microbiology named after N. F. Gamalei, Russian Ministry of health (NIZAM) was tested by its vector vaccine from COVID-19, and the experience was a success: the immune system is, the negative effects are not detected, reported “Interfax” Director of the center academician Alexander Ginzburg.
“as for developers, Yes, they are not so much experiencing, how to protect themselves, in order in a pandemic then they could develop (…) All those involved in the development of, respectively, all protected,” said Ginzburg in an interview.
Responding to a question about whether there were side effects, the academician replied: “No. All alive, healthy and happy”. He did not specify the number of colleagues who have injected themselves with a vaccine, however, according to him, this is a wide range of the center staff, the developers, the organizers of preclinical studies and technologies.
Gunzburg explained that we are talking about a promising vector vaccine of NIZAM based on DNA, adenovirus, in which the integrated gene of the coronavirus SARS-CoV-2. Adenovirus is used as a “container” to deliver coronavirus gene in a cell, start there protein synthesis shell of a new coronavirus (the same “crown”, through which the coronavirus got their name) and “introduce” in this way the immune system with a potential enemy. Vaccines of this type are called vector.
